Additionally, ERBB2ΔEx16 was also detected without ERBB2 amplification in a treatment-naïve LC patient and an OC patient, neither of whom carrying LC-associated oncogenic driver alterations. The gene discussed is ERBB2; the disease is laryngotracheoesophageal cleft.